SenesTech Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St · 03/14 11:40

SenesTech (NASDAQ:SNES) Full Year 2024 Results

Key Financial Results

  • Revenue: US$1.86m (up 56% from FY 2023).
  • Net loss: US$6.18m (loss narrowed by 20% from FY 2023).
  • US$8.86 loss per share (improved from US$115 loss in FY 2023).
earnings-and-revenue-history
NasdaqCM:SNES Earnings and Revenue History March 14th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

SenesTech EPS Beats Expectations, Revenues Fall Short

Revenue missed analyst estimates by 10.0%. Earnings per share (EPS) exceeded analyst estimates by 13%.

Looking ahead, revenue is forecast to grow 37% p.a. on average during the next 3 years, compared to a 8.3% growth forecast for the Pharmaceuticals industry in the US.

Performance of the American Pharmaceuticals industry.

The company's shares are down 17% from a week ago.

Risk Analysis

Before we wrap up, we've discovered 6 warning signs for SenesTech (3 are significant!) that you should be aware of.